Unusual DNA binding modes for metal anticancer complexes.
about
Noble metals in oncologyProbing of the interaction between β-lactoglobulin and the anticancer drug oxaliplatin.Anticancer activity of methyl-substituted oxaliplatin analogs.Preliminary study of mechanism of action of SN38 derivatives. Physicochemical data, evidence of interaction and alkylation of DNA octamer d(GCGATCGC)2.FAB, ESI and MALDI Mass Spectrometric methods in the study of metallo-drugs and their biomolecular interactions.Ru binding to RNA following treatment with the antimetastatic prodrug NAMI-A in Saccharomyces cerevisiae and in vitroPreparation of organometallic ruthenium-arene-diaminotriazine complexes as binding agents to DNA.Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.A first-in-class and a fished out anticancer platinum compound: cis-[PtCl2(NH3)2] and cis-[PtI2(NH3)2] compared for their reactivity towards DNA model systems.Novel metals and metal complexes as platforms for cancer therapyInvestigations of the binding of [Pt2(DTBPA)Cl2](II) and [Pt2(TPXA)Cl2](II) to DNA via various cross-linking modes.Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.Anticancer activity of metal complexes: involvement of redox processes.Targeted and multifunctional arene ruthenium chemotherapeutics.Benzyl-substituted metallocarbene antibiotics and anticancer drugs.Binding of an organo-osmium(II) anticancer complex to guanine and cytosine on DNA revealed by electron-based dissociations in high resolution Top-Down FT-ICR mass spectrometry.Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.Ruthenium complexes as antimicrobial agents.Structural analysis of small to medium-sized molecules by mass spectrometry after electron-ion fragmentation (ExD) reactions.Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocines.A comparative DFT study on aquation and nucleobase binding of ruthenium (II) and osmium (II) arene complexes.The influence of RAPTA moieties on the antiproliferative activity of peripheral-functionalised poly(salicylaldiminato) metallodendrimers.Does cytotoxicity of metallointercalators correlate with cellular uptake or DNA affinity?Structure-activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4'-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity.Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.Cytotoxic and antimicrobial activities of Cu(II), Co(II), Pt(II) and Zn(II) Complexes with N,O-chelating heterocyclic carboxylates.A glycine ruthenium trithiacyclononane complex and its molecular encapsulation using cyclodextrins.Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339.Intercalation processes of copper complexes in DNA.Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender DifferencesInteraction of Newly Platinum(II) with Tris(2-carboxyethyl)phosphine Complex with DNA and Model Lipid Membrane.Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands.Specific blocking of CREB/DNA binding by cyclometalated platinum(II) complexes.Fortification of blood plasma from cancer patients with human serum albumin decreases the concentration of cisplatin-derived toxic hydrolysis products in vitro.Chemoprotection by D-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma.Syntheses, crystal structures, DFT calculations, protein interaction and anticancer activities of water soluble dipicolinic acid-imidazole based oxidovanadium(iv) complexes.Parity-dependent hairpin configurations of repetitive DNA sequence promote slippage associated with DNA expansion.Special issue: practical applications of metal complexes.Exploring the boundaries of direct detection and characterization of labile isomers - a case study of copper(ii)-dipeptide systems.Control of Reversible Activation Dynamics of [Ru{η6 :κ1 -C6 H5 (C6 H4 )NH2 }(XY)]n+ and the Effect of Chelating-Ligand Variation.
P2860
Q26777745-4DDB8DEB-951E-4D7B-BEAB-4BA43F09F329Q30153309-F9464049-AEE7-46B4-9362-D9D3F5D1DB03Q30515979-5A7D8F6C-D27B-40E8-8CE7-F50CEBC8EB36Q31125490-BD6CC39E-3091-4E39-9640-638791407AADQ33869892-D11D4D02-F780-4AA1-9DC9-F7D59E645D39Q33955538-6CB4E886-CB46-422B-9EB5-D70637ADA371Q34151556-97A1CC79-2799-4605-8CA6-2D55962F9B7DQ35845089-4D1721C0-02F8-472B-B316-C540E7A84103Q36002521-4241B406-6154-4853-A42A-7412A6931FE7Q37137649-22B5B9EC-A05D-4739-A24B-148DC48504BAQ37291146-0E9CE8F7-FC32-454E-BD26-8D2AACB3F058Q37441359-3D1FD44B-5871-4EC4-8EED-3780E5CF1277Q37833099-2CE9793C-E596-40C3-9241-82A20422B949Q37920741-5A60973F-71AE-4C48-B503-77C1E30F1BE3Q38207472-35D43A64-965E-4BB2-B341-37F2FBB261BAQ38301265-97B2C00F-D98D-4BD3-9F5F-05FE8477D84DQ38328481-BC3DD75C-7D8F-4911-B7C4-46E240676896Q38365877-8A8DF35D-A971-49FF-A58B-6DF93BE11C81Q38685618-42F19E1F-1454-4769-9CCC-838D02A01CE4Q38742130-8DAC8293-4C6D-41B1-A636-EF95DF1D81A6Q39095894-D372661C-267F-4926-86BA-27AF870B8C1DQ39246566-C705AF96-6E89-4E49-83F0-6B76E1E72648Q39323998-F290F2A1-BE9D-44B4-9F33-888297043AA3Q39471213-A8A4E08E-5603-4ABE-8F93-C50CF77FD573Q39497208-D0B13479-31C9-42C9-BD08-C47104521D93Q39520245-0E805D2B-9B4F-4167-A216-2F67A65085C7Q39780060-E582464E-9289-40E2-B471-682838AEF492Q42040747-5128A414-A376-4970-B876-1FF2E21E28E7Q42210092-8819EE64-B590-410B-92B2-750ED7D2A770Q42343539-48FED7EA-F41E-4537-BF6D-B4D0BA2FEB14Q42363776-B1D7B148-9DD0-408D-8670-5EB8759AADEDQ42400560-2580EA2E-6317-45D8-9B10-969AEF380B85Q42692990-B9E461A4-651F-4C42-94EC-E7C4F11CC51AQ46834044-B6A42A11-2FDE-4A8D-8FF1-D0B55C466E97Q46959686-C1ED7050-36C2-4BB2-98A0-61D17DEA9CF2Q47370995-4B48A4F9-49CD-4CB9-AACB-EAFE31280941Q48208333-9C61C202-6F57-41BC-9B1B-7BA13D8AC8F6Q48264159-7E277109-94E7-4492-A455-95C6EACE347CQ48288565-10CAE208-070C-4D7F-A09A-97212F4A9CDBQ48362702-7EBC5AE7-AA64-434D-BDB8-78D07442DC75
P2860
Unusual DNA binding modes for metal anticancer complexes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Unusual DNA binding modes for metal anticancer complexes.
@ast
Unusual DNA binding modes for metal anticancer complexes.
@en
Unusual DNA binding modes for metal anticancer complexes.
@nl
type
label
Unusual DNA binding modes for metal anticancer complexes.
@ast
Unusual DNA binding modes for metal anticancer complexes.
@en
Unusual DNA binding modes for metal anticancer complexes.
@nl
prefLabel
Unusual DNA binding modes for metal anticancer complexes.
@ast
Unusual DNA binding modes for metal anticancer complexes.
@en
Unusual DNA binding modes for metal anticancer complexes.
@nl
P2860
P1433
P1476
Unusual DNA binding modes for metal anticancer complexes.
@en
P2093
Peter J Sadler
P2860
P304
P356
10.1016/J.BIOCHI.2009.03.017
P577
2009-04-01T00:00:00Z